ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 563,34
1,07%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. NRX Pharmaceuticals Inc (NRXP)

  7. NRX Pharmaceuticals Inc (NRXP) Actualités

NRXP NRX Pharmaceuticals Inc

2,07
0,01 (0,49%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
NRX Pharmaceuticals Inc NRXP NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,01 0,49% 2,07 06:00:07
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
2,13 2,01 2,44 2,10 2,06
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
30/4/202414:30PRNUSNRx Pharmaceuticals (Nasdaq:NRXP) Announces Promising..
18/4/202414:32PRNUSNRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice from..
18/4/202414:30PRNUSNRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million..
17/4/202422:45PRNUSNRx Pharmaceuticals, Inc. Announces Proposed Underwritten..
17/4/202414:30PRNUSNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces New Data..
15/4/202414:30PRNUSNRx Pharmaceuticals (NASDAQ:NRXP) Announces Development of..
08/4/202414:30PRNUSNRx Pharmaceuticals (NASDAQ:NRXP) Announces Data-Lock of..
01/4/202414:28PRNUSNRx Pharmaceuticals (Nasdaq:NRXP) Reports Fourth Quarter and..
28/3/202413:03PRNUSNRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth..
28/3/202413:00PRNUSNRx Pharmaceuticals Announces Reverse Stock Split to..
26/3/202421:03PRNUSUPDATE: NRx Pharmaceuticals (NASDAQ: NRXP) to Report Fourth..
25/3/202413:30PRNUSNRx Pharmaceutical's (NASDAQ:NRXP) Chairman Dr. Jonathan..
21/3/202421:02PRNUSNRx Pharmaceuticals to Report Fourth Quarter and Full Year..
21/3/202418:57PRNUSNRx Pharmaceuticals Announces Results of the Vote Held..
12/3/202412:49PRNUSNRx Pharmaceuticals (NASDAQ:NRXP) Initiates Strategy to..
11/3/202422:16EDGAR2Form DEF 14A - Other definitive proxy statements
11/3/202413:30PRNUSNRx Pharmaceuticals (NASDAQ:NRXP) Completes Memorandum of..
06/3/202422:08EDGAR2Form 8-K - Current report
04/3/202414:30PRNUSNRx Pharmaceuticals (NASDAQ: NRXP) Announces Last Patient,..
01/3/202414:30PRNUSNRx Pharmaceuticals Announces Definitive Purchase Agreement..
28/2/202423:09EDGAR2Form 8-K - Current report
28/2/202416:40EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
27/2/202416:49PRNUS/C O R R E C T I O N -- NRx Pharmaceuticals, Inc./
27/2/202414:54PRNUSNRx Pharmaceuticals, Inc. Announces Pricing of $1.5 Million..
26/2/202423:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
26/2/202422:01PRNUSNRx Pharmaceuticals, Inc. Announces Proposed Underwritten..
26/2/202414:30PRNUSNRx Pharmaceuticals (Nasdaq:NRXP) Launches HOPE..
20/2/202414:30PRNUSNRx Pharmaceuticals (Nasdaq:NRXP) to Launch HOPE..
14/2/202422:30EDGAR2Form 8-K - Current report
14/2/202412:03EDGAR2Form 8-K - Current report
12/2/202414:30PRNUSNRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Advance..
09/2/202414:30PRNUSNRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Reports Comments by..
05/2/202412:48PRNUSNRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces the..
02/2/202422:37EDGAR2Form 8-K - Current report
23/1/202422:16EDGAR2Form 8-K - Current report
22/1/202412:48PRNUSNRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces..
17/1/202412:48PRNUSNRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Receipt..
17/1/202400:36EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/1/202413:25DJNNRx Pharmaceuticals Gets Fast-Track Designation for NRX-101..
16/1/202412:48PRNUSNRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces FDA..
02/1/202414:45PRNUSNRx Pharmaceuticals (Nasdaq: NRXP) to Present Keynote..
02/1/202412:48PRNUSNRx Pharmaceuticals (Nasdaq: NRXP) Demonstrates Compliance..
29/12/202322:30EDGAR2Form PRE 14A - Other preliminary proxy statements
29/12/202322:15EDGAR2Form 8-K - Current report
27/12/202312:48PRNUSNRx Pharmaceuticals Announces the Election of Janet..
21/12/202322:05EDGAR2Form 8-K - Current report
19/12/202314:15PRNUSNRx Pharmaceuticals Announces Signing of a Data and..
18/12/202312:48PRNUSNRx Pharmaceuticals Announces FDA Clearance of its..
13/12/202322:02PRNUSNRx Pharmaceuticals Provides Notice of Annual Meeting of..
11/12/202312:48PRNUSNRx Pharmaceuticals to Participate in LifeSci Corporate..

Dernières Valeurs Consultées

NASDAQ
NRXP
NRX Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés